Nkọwapụta Peptide Membrane: 6-Nzọụkwụ Mee Framework

Nkọwapụta Peptide Membrane: 6-Nzọụkwụ Mee Framework

Kedu nkọwapụta Peptide Membrane nwere n'ezie

akwụkwọ nkọwapụta edobere dị ka tebụl ule, usoro, na kọlụm nnabata-ụkpụrụ, jiri ahịrị ịdị ọcha pụta ìhè iji gosi na ọ bụ otu ahịrị a

Nkọwapụta akpụkpọ ahụ peptide bụ ndepụta ule, ntụaka na usoro nyocha, na njirisi nnabata egosipụtara dị ka oke ọnụọgụgụ, oke, ma ọ bụ njirisi ndị ọzọ. Ọ na-ekwu ihe ọtụtụ ga-adabarịrị tupu anabata ya maka iji ya eme ihe, na a na-atụpụta ya ma kwado ya site n'aka onye nrụpụta kama inyefe ya nke ọma (nkọwa ICH nke nkọwapụta, I Q6A, Disemba 2000).

Nkọwapụta Peptide Membrane: 6-Nzọụkwụ Mee Framework

Akwụkwọ abụọ na-ekewa ọrụ, na mgbagwoju anya ha bụ mgbọrọgwụ nke nkọwa adịghị ike. Q2(R2) na-egosi na usoro ahụ dabara maka ebumnuche; Q6A na-akọwa ihe a ga-anwale na nsonaazụ a na-anabata. Akụkụ nkwado bụ ihe: I Q2(R2) Usoro-nkwado atụmanya na-ekpuchi izi ezi, nkenke, nkọwapụta, njedebe nchọpụta, oke ọnụọgụ, linearity, na nso maka usoro eji na ntọhapụ na nkwụsi ike ule, na ngbanwe ahụ wee bụrụ nke ọma n'ụzọ iwu kwadoro 14 June 2024.

Ngalaba nkọwapụta

Isi iyi na-achị

Ọnọdụ

njirimara

I Q6A

Edepụtara I/EMA

Nyocha / ọdịnaya

I Q6A

Edepụtara I/EMA

Ịdị ọcha

I Q6A

Edepụtara I/EMA

Profaịlụ adịghị ọcha

I Q6A / Q3A

Edepụtara I/EMA

Counter-ion

Akọwapụtara ngwa

Akọwapụtara ngwa

HMW / mkpokọta

Akọwapụtara ngwa

Akọwapụtara ngwa

Solubility

Akọwapụtara ngwa

Akọwapụtara ngwa

Arụmọrụ arụrụ arụ

Akọwapụtara ngwa

Akọwapụtara ngwa

Ọdịnaya mmiri

USP <921>

USP isi-achịkwa

Endotoxins

USP <85>

Peptide Synthesis USP isi-achịkwa

Kwupụtanụ

USP <788>

USP isi Peptides sịntetik r-achị

Nkwụsi ike nchekwa

I Q1A

Ọrụ Edepụtara I/EMA

Ịkpọ aha / traceability

21 CFR 201

Akọwapụtara ngwa

Tebụl: ngalaba nkọwapụta akpụkpọ ahụ peptide e debere na isi mmalite na-achị achị yana ọkwa nnabata COA.

Ihe ndị ọzọ n'usoro a na-ewulite ise n'ime ngalaba ndị ahụ n'usoro: njirimara na nyocha, profaịlụ adịghị ọcha na counter-ion, ihe egwu mkpokọta, solubility na ebu n'obi nyocha ihe nchekwa, na nchekwa na njikwa. Ịkpọ aha na traceability na-emechi akaghị.

Nkọwapụta Peptide Membrane: 6-Nzọụkwụ Mee Framework

Ihe kpatara pasentị ịdị ọcha naanị ada ada dị ka ntọhapụ mwepụta

Pasent mpaghara kacha elu na-aza otu ajụjụ: ole nke mgbama UV na 214 nm eluted na windo a na-atụ anya ya. Ọ naghị agwa gị ihe pasent nke fọdụrụ bụ. Akụkọ teknụzụ Sigma-Aldrich na peptide adịghị ọcha depụtara klaasị adịghị ọcha ọnụọgụ ịdị ọcha na-ezo: usoro nhichapụ na mkpọpu, ngwaahịa mgbochi ezughị ezu, ngwaahịa oxidation, dimeric na oligomeric ụdị, na ihe ndị ọzọ reagent dị ka HBTU, Ntụpụ ụkwụ, ma ọ bụ ikpochapụ adcts. Nke ọ bụla nwere nsonaazụ ndu ya na nyocha ya, ma ọ nweghị nke edoziri ma ọ bụ gbakọọ ya n'otu n'otu site na pasent kachasị elu.

Ọdịiche ahụ bụ ebe akwụkwọ nyocha nke peptide chọrọ na-emebikarị. Ọtụtụ tọhapụrụ na 98% nwere ike ka na-ada na reconstitution ma ọ bụ na assay, n'ihi na 2% ọ dịghị mgbe e ji mara. njirimara Counter-ion bụ akụkụ nke otu ntụpọ ahụ: a 2020 nyochaa na Ọgwụ ọgwụ kọrọ na protein imeju ndị TFA gbanwere na-ebute nzaghachi T-cell ma kwalite mmepụta cytokine proinflammatory., nke mere na njirimara counter-ion ji bụrụ na nkọwapụta karịa na ederede ala ala. Otu akwụkwọ akụkọ ahụ 2025 Akwụkwọ nkwenye TFA na-agbakwụnye na trifluoroacetate fọdụrụnụ nwere ike iwebata njehie ịdị arọ site na ọdịiche dị arọ nke ụdị nnu, peptide mgbanwe mgbanwe, ma tinye aka na mkpebi nke abụọ site na CD na FT-IR.

Ịdọ aka ná ntị: RP-HPLC ngalaba-elutes ụdị nwere hydrophobicity yiri ya, yabụ enweghị ike ịgụ otu nọmba ịdị ọcha dị ka profaịlụ adịghị ọcha zuru oke.

Nzọụkwụ 1: Kọwaa njirimara na njirisi nnabata nke nyocha

akara RP-HPLC nwere ọnụ ọgụgụ kacha elu agbakwunyere yana mpaghara adịghị ọcha n'etiti ọnụ ọnụ kacha elu na ihu ihe mgbaze nke ejiri oge njigide.

N'ọgwụgwụ nke usoro a, ị ga-edewo mpaghara abụọ n'ime nkọwapụta peptide akpụkpọ ahụ: a kwadoro molekul uka na usoro ya, yana njirisi ọdịnaya peptide nwere oke ọnụọgụ. Ha jikọtara ọnụ na-emechi oghere ahụ na-eme ka onye na-agụ ya ghara ikwu ihe akwadoro oke ma ọ bụ ihe ọdịnaya bara uru akwụkwọ akụkọ nyocha..

Identity na-ebute ụzọ n'ihi na mpaghara ọ bụla na-esote dabere na ya. Electrospray ionization mass spectrometry (ESI-MS) bụ ọkọlọtọ nkwenye: Uka a hụrụ ga-adabarịrị na nkezi usoro iwu nke usoro a chọrọ n'ime nnabata nke kwuru, A na-egosipụtakarị na daltons ma ọ bụ ppm. Dee usoro na ndidi n'ime nkọwapụta, ọ bụghị naanị nsonaazụ. A CoA na-akọ "oke kwadoro" na-enweghị uru a hụrụ, ọnụ ahịa gbakọọ, na usoro ngwá ọrụ abụghị ihe ntọhapụ.

Ogige ọdịnaya bụ ebe nhọrọ counter-ion na-emebi nọmba ahụ ozugbo. A 2018 mụọ na Amino acid chọpụtara na ngbanwe n'etiti chloride/acetate Ụlọ ahịa na ụdị TFA gbanwere ọdịnaya peptide tụrụ atụ site n'ike 10%, ebe ọrụ nyocha nke ndu egosighi nnukwu ọdịiche. Nke ahụ bụ ụdị nkwuwa okwu nke nkwupụta counter-ion: mmetụta counter-ion abụghị eluigwe na ala, na ole ha dị mkpa dabere na peptide gị na nyocha gị.

Nke Ọgwụ ọgwụ Akwụkwọ nkwenye TFA na-akọwapụta ego ole TFA peptide "dị ọcha" ka nwere ike iburu: ruo 35% nke ngụkọta arọ na ọmụmụ mgbanwe, na chloride erute ruo 10%. Ekwesịrị ede oke ọdịnaya gị megide eziokwu ahụ, dị ka ọnụ ahịa a tụrụ na usoro, ọ bụghị dị ka echiche na pasent ịdị ọcha na-ekpuchi ya.

Nyocha: maka oke nke gi, ị nwere ike ikwupụta ihe akwadoro oke, kedu usoro na ndidi, na kedu ọdịnaya bara uru akụkọ CoA, na ihe analytic ndabere. Okwu abụọ ahụ bụ ntọala nke ogo peptide dị njikere ngwa.

Nzọụkwụ 2: Tọọ Profaịlụ adịghị ọcha yana ogige Counter-ion

Site na njedebe nke nzọụkwụ a, nkọwapụta gị aha adịghị ọcha ọ bụla ị dị njikere ịnakwere wee kwuo counter-ion, ya na nọmba etinyere na ya.

Malite na mpaghara adịghị ọcha. Depụta klaasị adịghị ọcha amaara iche, nye ya oke, ma kpọọ aha usoro na-atụ ya. Otu ahịrị "ihe metụtara ≤ 2.0%" na-ezochi adịghị ọcha ị na-anabata..

Mgbe ahụ tinye ubi counter-ion. Nke a bụ mpaghara ọtụtụ nkọwa wepụrụ, na ọ bụ ya na-ekpebi ma nyocha gị ọ na-arụ ọrụ. N'ihi na ọtụtụ ọgwụ peptide akwadoro bụ nnu acetate akụkụ iji zere nsị trifluoroacetate., njirimara counter-ion bụ na nkọwapụta yana na labelụ, ọ bụghị naanị na chromatogram (Ọgwụ ọgwụ 13(12):442, 2020).

Usoro ahụ na-akọwa ihe mere ubi ahụ ji dị mkpa. Trifluoroacetate ion-pairs nwere otu ndị bụ isi na N-terminus na Arg, Ya na Lys, na-echebe polarity, na-ewelite oge njide na lipophilicity, na ịlanarị lyophilization dị ka nnu peptide-TFA. Ya mere, peptides sịntetik na-ebufe TFA⁻ kwa peptide karịa ka usoro ahụ si buru amụma. (Ọgwụ ọgwụ 18:1163, 2025).

Ihe fọdụrụ ahụ abụghị inert. TFA fọdụrụnụ na nlele peptide nwere ike ịgbanwe izi ezi na mmụgharị nke nyocha ekwentị., na-egbochi mmụba cell, na mgbagwoju anya na ọrụ vivo (Ọgwụ ọgwụ 18:1163, 2025). CoA nke na-ekwu "Nnụ TFA" na-enweghị ọnụọgụ na-ahapụ gị enweghị ike ikpebi nnyonye anya ahụ, nke bụ ya mere akwụkwọ nyocha peptide kwesịrị iji na-emeso counter-ion dị ka mpaghara ọnụọgụ karịa karịa nkọwa nkọwa..

Nyocha: CoA na-akpọ counter-ion ma na-akọwapụta ya. Ọ bụrụ na ọ bụghị, nkọwapụta ezughị ezu.

Nzọụkwụ 3: Ezipụta ihe egwu nchịkọta na usoro Orthogonal

vial abụọ nke ngwọta peptide emegharịrị, otu doro anya na nke na-egosi haze a na-ahụ anya na ezigbo particulate, esere foto megide ndabere gbara ọchịchịrị

Site na njedebe nke nzọụkwụ a, nkọwapụta gị nwere mpaghara nchịkọta nwere usoro aha ya, oke ọnụọgụgụ, na njedebe ederede. Nchịkọta bụ mpaghara nkọwapụta, ọ bụghị paragraf ịkpachara anya.

Maka ngwaahịa peptide zuru oke, Atụmanya mkpokọta FDA na ngwaahịa ntụaka bụ na mkpokọta ekwesịghị ịgafe ọkwa a hụrụ na ntụnye aka edepụtara, tozuru oke site na ọkwa RLD a hụrụ na ya na-akwado ya site na ọmụmụ nzaghachi nzaghachi mgbochi ọrịa (Ntuziaka ntụnyere njiri mara FDA, 14 Disemba 2022). Ebe RLD adịghị, arịlịka ahụ adịghị na ị ga-edozi oke site na data mmepe nke gị.

Nnwale mkpokọta Peptide (SEC/DLS) abụọ ụzọ abụọ n'ihi na ọ bụghị nke zuru ezu naanị. chromatography nke mwepu oke na-agụta ụdị dị arọ dị elu megide usoro usoro, ma ọ nwere ike n'okpuru-akọ obere oligomers na elute nso monomer elu. Mgbasa ọkụ na-agbanwe agbanwe na-achọpụta ụdị ndị ahụ site na radius hydrodynamic, ma ihe si na ya pụta bụ itinye uche- na echekwa-enwe mmetụta, ya mere ọ bụ naanị atụnyere mgbe a na-atụle ihe nlele ahụ n'ụdị ezubere na ntinye uche. Dee mmachi abụọ ahụ n'ime nkọwapụta ka a ghara ikpe nza n'ọdịnihu megide ọnụọgụ nke usoro enweghị ike ịgbachitere. Ihe gbasara

Nke USP <788> oke urughuru na-enye gị ala nchekwa maka subvisible particulates, na otu isiakwụkwọ na-achọ subvisible elele urughuru nke ọ bụla ọgwụ ogbe dị ka akụkụ nke nza ntọhapụ (Nkọwapụta onyonyo mmiri mmiri, emelitere maka 1 Ọgọst 2026 ngbanwe kwekọrọ).

Nyocha: megharia otu otutu na ntinye a kapịrị ọnụ n'ime ihe nchekwa echere, Gbaa SEC na DLS n'otu nkwadebe ahụ, ma gosi na nsonaazụ abụọ a dabara na oke idere. Ọ bụrụ naanị otu usoro na-agafe, oke erubeghị ọkwa ntọhapụ.

Nzọụkwụ 4: Nwalee Solubility na Nchekwa Assay Ezubere

Site na njedebe nke nzọụkwụ a, nkọwapụta gị na-ebu criterion solubility edere megide ihe nchekwa nnwale gị na-eji n'ezie, ọ bụghị megide mmiri. Solubility bụ naanị ihe bara uru mgbe a tụrụ ya na ọkara nke nyocha ahụ ga-abanye, n'ihi na otu nza ahụ nwere ike igbari nke ọma na mmiri na gel na saline phosphate buffered n'otu ntinye uche.

Na-arụ ọrụ n'usoro. Gbanwee itinye uche na-arụ ọrụ mkpa nyocha gị, wee dozie ihe nchekwa peptide reconstitution na assay pH na ike ionic kama ndabara dabara adaba. Gbaa usoro ịta ahụhụ elu site na itinye uche na-arụ ọrụ, ma dekọọ ntinye uche kachasị elu nke na-enye ngwọta doro anya na-enweghị ihe ndị a na-ahụ anya. Uru ahụ na-aghọ oke ngafe / ọdịda na nkọwapụta.

Ụdị ọdịda bụ nke na-efu oge kachasị: ọtụtụ ewepụtara megide ụkpụrụ mmiri solubility nke ígwé ojii ma ọ bụ gels ozugbo ọ ruru ihe nchekwa nyocha.. Akwụkwọ ahụ gafere, a na-anabata nza, na nnwale ahụ ada ada n'ụbọchị mbụ.

Maka ndụmọdụ: Solubility bụ ihe nchekwa -, pH- na okpomọkụ dabere, Ya mere, a na-ebufe ya naanị ma ọ bụrụ na ihe nchekwa ihe mejupụtara, Edere pH na okpomọkụ n'ime nkọwapụta n'akụkụ oke.

Nzọụkwụ 5: Dee Ọnọdụ Nchekwa na Ijikwa Iwu n'ime nkọwapụta

Site na njedebe nke nzọụkwụ a, Nkọwapụta gị ga-ebu nchekwa na njikwa nkebiokwu na-achọpụta na ebe ebipụtara kama ahịrị ndị na-ere ahịa depụtaghachiri..

Peptides bụ hygroscopic. Ntinye mmiri na-ebelata ọdịnaya peptide n'ozuzu ma nwee ike ibelata nkwụsi ike, ya mere nkọwapụta ahụ kwesịrị ịchọ ka arịa ahụ rute okpomọkụ n'ime ebe a na-ehicha ihe tupu imeghe ma mechie ya nke ọma ma emesịa. (Ntuziaka njikwa na nchekwa Bachem, ibe dee ya 2026-07-28). Ahịrịokwu abụọ ahụ bụ ntọala niile maka ndebiri nkebiokwu dị n'okpuru.

Ọnọdụ

Akpa

Ijikwa nzọụkwụ

Ụdị ọdịda nkebiokwu ahụ na-egbochi

Lyophilized ntụ ntụ, ogologo oge

Akara akara, desicated, echebe site na ìhè

Dakọtara na ambient na desiccator tupu imeghe; mechie nke ọma

Condensation na ntụ ntụ, nnabata mmiri, ọdịnaya peptide na-ada

Ngwọta na-arụ ọrụ

Ekwupụtara ya, ọ bụghị otu ngwaahịa

Kpoo ma kpochaa n'okpuru -15 Celsius; jide naanị izu ole na ole

Usoro mgbaze ugboro ugboro yana nbibi usoro ngwọta

Usoro na Asn, Gln, Cys, Met ma ọ bụ Trp

Dị ka n'elu

Zere nchekwa ihe ngwọta ogologo oge

Deamidation na oxidation na labile residues

Ọnụọgụ abụọ na-ekesa ebe niile na akwụkwọ ndị na-ere ahịa: ndụ nchekwa otu afọ ruo atọ na -20 Celsius C yana mfu pasentị abụọ ruo ise n'otu oge na-agbaze oyi.. Ọnweghịkwa ọmụmụ ihe elu nwere ike ịmata, Ya mere, ọ bụghịkwa na nkọwapụta ị ga-agbachitere. Dee nkebiokwu ahụ dị ka ọnọdụ yana iwu njikwa, ma mee ka data nkwụsi ike nke ị na-emepụta mejupụta na etiti oge.

Nzọụkwụ 6: Jiri Labeling na traceability mechie Loop

vial peptide n'akụkụ akwụkwọ nyocha nke ebipụtara, na nọmba nza, ubi counter-ion na ahịrị ọdịnaya net kpọpụtara na ha abụọ

Site na njedebe nke nzọụkwụ a, akpa na friza, akwụkwọ nyocha na faịlụ gị, na data ntọhapụ dị n'azụ akwụkwọ ahụ na-arụtụ aka n'otu ebe na-enweghị ajụjụ nye ndị na-ebubata ya.

Ịkpọ aha bụ ubi nkọwapụta, ọ bụghị echiche ọzọ. Otu echiche dị n'azụ ihe kpatara njirimara counter-ion ji dị na nkọwapụta na-emetụta akara n'onwe ya: Ọ bụrụ na ụdị counter-ion na-ebi naanị na chromatogram, onye nọ na bench enweghị ike ịhụ ya. Asambodo nyocha nke peptide gị kwesịrị ịkpọ aha, na ma labelụ na CoA, ihe nchọpụta nza, ụdị counter-ion, net peptide net dị iche na nha nnu net, ọnọdụ nchekwa, na ntughari nke CoA ka ewepụtara nza megide.

Agbụ ahụ bụ ihe atụmanya data-iguzosi ike n'ezi ihe n'okpuru ụkpụrụ MHRA ALCOA kọwara dị ka ihe ndekọ nwere ike ịpụta na nke enwere ike ịchọpụta.: ntinye nke ọ bụla na-ejikọta na mmalite akọwapụtara kama icheta.

Ụdị ọdịda ahụ dị jụụ ma dị oke ọnụ. Akara akara nke na-ekwupụta ịdị arọ nnu mgbe nyocha ahụ na-akọ ọdịnaya peptide na-eduga onye nyocha ịtụ ego na-ezighi ezi, na data nke si na ya bu njehie na-enweghị nyocha nke ala ga-egosipụta.

Nyocha: Were akpa ọ bụla n'ime nza wee chọpụta ya na CoA na data ntọhapụ ya. Ọ bụrụ nchọta ahụ chọrọ ozi-e, nkọwapụta adịghị emechi.

Mmejọ ndị a na-emekarị iji zere

Ọdịda na-adịkarịkarị bụ ịgwọ CoA dị ka nnata karịa ka nkọwapụta, yabụ enweghị usoro nnabata COA ka edebere. Nza ahụ gafere n'ihi na ọ nweghị onye kọwara ihe ọdịda ga-adị ka ya.

Na-akọwapụta ịdị ọcha na-enweghị profaịlụ adịghị ọcha. Otu pasent dị ọcha na-ezobe klaasị adịghị ọcha dị n'okpuru ya, gụnyere usoro ihichapụ, iberibe iberibe, na diastereomers nke dị iche na uka site na ihe ọ bụla. Ọ na-eme n'ihi na ịdị ọcha bụ otu ọnụ ọgụgụ onye ọ bụla na-ere ahịa na-akọ na onye ọ bụla na-azụ ahịa ghọtara. Ndozi bụ ide profaịlụ n'ime nkọwapụta: nke klas adịghị ọcha ga-akọrịrị, kedu mkpebi, na ihe kacha maka nke ọ bụla bụ. Nza dara ada dị ka 97% ịdị ọcha na enweghị ọnụọgụgụ 2% nke ahụ ga-abụ usoro mkpochapụ na-emekọ ihe ọnụ.

Ịnabata ogige counter-ion oghere ma ọ bụ enweghị ọnụọgụ. Nke a bụ ya mere njirimara counter-ion ji bụrụ na nkọwapụta yana na labelụ, ọ bụghị na ndetu ala ala peeji. Ọ na-eme n'ihi na "TFA nnu" na-agụ dị ka azịza zuru ezu mgbe ọ bụ naanị aha. Ndozi ahụ bụ ịchọ ka achọpụta counter-ion ma gbakọọ ọdịnaya ya fọdụrụnụ, na oke kwuru. Nza dara ada dị ka peptide nke oke ya dabara na ntọala efu, ọ bụghị ụdị nnu ị nwara megide.

Ntọhapụ megide mmiri solubility. Mmiri abụghị ihe nchekwa nyocha. Ọ na-eme n'ihi na mmiri bụ ihe mgbaze onye ọ bụla nwere n'aka na ọnụ ọgụgụ dị mfe ịmepụta. Ndozi bụ ịgba ọsọ ule peptide solubility n'ime ihe nchekwa nke nyocha ahụ na-eji n'ezie, na ịta ahụhụ n'ezie na-agba ọsọ. Otu nza dara ada dị ka peptide nke na-agbaze nke ọma na mmiri ma na-ebuli ya ozugbo ọ kụrụ saline nwere phosphate buffered..

Na-eṅomi windo nchekwa ndị na-ere ahịa na-achọpụta na enweghị ọmụmụ ihe elu. Ọnọdụ nchekwa nke dị na nkọwa ahụ bụ nke mmadụ tụrụ, ọ bụghị ndị akwụkwọ data ketara. Ọ na-eme n'ihi na windo ekwuru na ọ dị nchebe karịa nke ekwughị. Ndozi bụ ịchọ ihe ndabere maka windo, ma ọ bụ iji mepụta data nkwụsi ike nke gị. Nza dara ada dị ka peptide echekwara kpọmkwem dị ka a gwara ya nke na-adaghị njirimara na nyocha ọzọ.

Ịde aha site na ịdị arọ nnu mgbe nyocha ahụ na-akọ ọdịnaya peptide. Ọnụọgụ abụọ ahụ dị iche site na counter-ion uka, na oghere ahụ buru ibu nke na-eme ka ọ bụrụ ihe dị na obere milligram akpịrịkpa. Ọ na-eme n'ihi na akara na nyocha bụ nke ndị dị iche iche nwe. Ndozi bụ ikwupụta ntọala nke akara ahụ na-eji yana mee mkpesa nyocha n'otu ntọala ahụ.

Ntugharị igodo: Ebe nkọwapụta na-adị adị naanị ozugbo edere ya wee lelee ya megide CoA. MOL mgbanwe na-akwado loop ahụ site n'ikwe ka otu otu kọwaa akara nnabata maka mpaghara enyere wee tulee CoA na-abata megide ya., ya mere ọnụ ahịa efu ma ọ bụ enweghị ọnụọgụ na-ebuli elu na nnata karịa na nyocha.

Kedu ihe ịga nke ọma dị ka

Ọ bụrụ na usoro ahụ dị, ị nwere ike inye ndị na-ebubata ngwaahịa otu akwụkwọ nke ubi ọ bụla nwere usoro aha ya, akara ọnụọgụ ma ọ bụ ngafe/ọdịda, na a kwuru ọdịda mode. Nke ahụ bụ ihe àgwà peptide dị njikere ngwa dị: ọ bụghị ọnụ ọgụgụ dị ọcha, mana nkọwapụta otu QC nwere ike ime n'ajụghị gị ihe ị pụtara.

Ugbu a, ị ga-ejide ihe artefacts anọ:

  • Tebụl ngalaba site na ngalaba mmeghe, na ngalaba isii niile ekenyere onye nwe na ule.

  • Ntinye nzọụkwụ isii: njirimara na njirisi nyocha, adịghị ọcha na counter-ion ubi, oke nchịkọta na usoro orthogonal, solubility rụpụtara na ihe nchekwa echere n'uche, nchekwa na njikwa nkebiokwu, na eriri akara.

  • Ndebiri nkebi nchekwa ị nwere ike iji ọzọ gafee nza, yabụ na-akwụsị idegharị ọnọdụ nchekwa peptide n'otu usoro.

  • Yinye akara nke na-ejikọta vial ọ bụla na CoA ya, oke ya, na njirisi ntọhapụ ya. Mmepụta Peptide

Ihe mgbaru ọsọ gbatịa bụ usoro nkwụsi ike. I Q2(R2) na-etinye atụmanya nkwenye nke usoro ya na usoro nyocha ọhụrụ ma ọ bụ nke edegharịgharịrị ejiri maka ntọhapụ na nkwụsi ike ule., nke pụtara na enwere ike nyochaa ntọhapụ gị ka oge na-aga karịa ịtọ otu ugboro na nza mbụ.

Jiri eserese emechara ka nlele aka gị. Ahịrị ọ bụla ka nwere oghere bụ ubi onye na-ebubata gị ga-akọwara gị.

Ajụjụ a na-ajụkarị

Kedu ihe dị iche n'etiti ICH Q6A na ICH Q2(R2)?

Ha zara ajụjụ abụọ dị iche iche. ICH Q6A na-akọwapụta ihe nkọwapụta ga-enwerịrị: nke agwa ule, na akara nnabata maka onye ọ bụla. I Q2(R2) na-achịkwa usoro nyocha n'azụ ule ndị ahụ, na-ekpuchi izi ezi, nkenke, nkọwapụta, oke nchọpụta na ọnụọgụgụ, linearity na oke. Na omume, Q2(R2) na-egosi na usoro ahụ dabara maka ebumnuche ebe Q6A na-akọwa ihe a ga-anwale, ya mere nkọwapụta nke depụtara oke na-enweghị usoro akwadoro n'azụ ya anaghị eju ma ọlị.

Enwere m ike iji counter-ion dị iche ma ọ bụrụ na TFA bụ nsogbu maka nyocha m?

Ee, na mmetụta dị adị ma ọ bụghị amụma. N'ime otu ihe ọmụmụ antimicrobial-peptide, ịgbanwere mpempe counter-ion gbanwere ọdịnaya atụnyere site na obere ihe 10% na-enweghị nnukwu ọdịiche dị na ọrụ nyocha nke ndu, nke na-egosi mmetụta counter-ion abụghị eluigwe na ala ma dabere na peptide na nyocha. Ebe nyocha gị nwere mmetụta nke trifluoroacetate fọdụrụnụ, acetate ma ọ bụ chloride bụ ihe eji dochie anya ya. Nke ọ bụla, Asambodo peptide gị nke nyocha chọrọ kwesịrị ịkpọ ụdị counter-ion wee kọwapụta ya, n'ihi na counter-ion ekwughị okwu na-eme ka ọdịnaya peptide net enweghị nkọwa.

Kedu otu m ga-esi tinye oke mkpokọta ma ọ bụrụ na enweghị m ntụnye aka edepụtara na ọgwụ?

Mepụta oke site na ntozu usoro nke gị. Gbaa SEC na DLS ọtụtụ ihe na-eme na nyocha gị, were nsonaazụ ahụ dị ka ntọala, ma tọọ akara nnabata na ma ọ bụ n'okpuru ya, na-ekwupụta usoro na njedebe ya na nkọwapụta. Rịba ama oke: Atụmanya mkpokọta FDA na ngwaahịa ntụaka na-emetụta ngwaahịa peptide zuru oke, ya mere ọ naghị ebufe ozugbo na ihe ọkwa nyocha. Ijikwa ihe egwu mkpokọta peptide na-enweghị RLD pụtara ntọala ntọala gị bụ arịlịka.

Achọrọ m USP <85> Nnwale endotoxin maka peptide akpụkpọ anụ nyocha?

Ọ dabere na ebumnuche ebumnuche. A na-agbakọ oke nkwụghachi ka K/M, na K = 5 EU/kg maka ọtụtụ ọgwụ parenteral na 0.2 EU/kg maka ọgwụ intrathecal, ebe M bụ oke bolus kwa kilogram kwa elekere, na usoro ahụ bụ nke ngwaahịa parenteral. Maka ihe nyocha-ọkwa, mgbakọ ahụ bụ ọnụ ụzọ dị larịị, na-emekarị <5 EU/mg, nwere ụkpụrụ siri ike akọwapụtara maka omenala cell ma ọ bụ ọrụ vivo. Ọ bụrụ na a na-ekwukwa na ịmụ nwa, USP <71> sterility chọrọ bụ 14 nnabata ụbọchị na Fluid Thioglycollate Medium na Soybean-Casein Digest Medium, na-agafe naanị na enweghị uto.

Ogologo oge ole ka peptide akpụkpọ ahụ lyophilized na-anọsi ike?

Enweghị otu ndụ shelf, na ọnụọgụ ọ bụla e hotara na-enweghị usoro bụ ntule. Nkwụsi ike dabere na usoro, counter-ion, ihe fọdụrụ mmiri, na okpomọkụ nchekwa ị na-edobe n'ezie. Ụzọ agbachitere bụ ikwupụta ọnọdụ nchekwa na nkọwapụta, wee kwado ụbọchị nnwale ahụ site na iji data nkwụsi ike nke onwe gị n'ọnọdụ ahụ kama ịgbazinye ọnụ ọgụgụ site na nduzi izugbe nke ndị na-ebubata ya..

Nzọụkwụ ọzọ

Ị na-ejidezi nkọwapụta akpụkpọ anụ peptide arụnyere site na ngalaba mkpebi isii: njirimara na njedebe nyocha, adịghị ọcha na counter-ion ubi, ihe egwu mkpokọta na ụzọ orthogonal, solubility na ebu n'obi nyocha ihe nchekwa, iwu nchekwa na njikwa, na akara nke na-eme ka a chọpụta nza ahụ. Ogige ọ bụla na-ebu ule, usoro, na akara nnabata, ya mere akwụkwọ ahụ na-eme ihe karịrị ịkọwa ihe. Ọ na-ejikọta nnwale ntọhapụ na arụmọrụ ị chọrọ n'ezie na nyocha, nke bụ oghere ọnụ ọgụgụ dị ọcha naanị na-ahapụ oghere.

Usoro ahụ na-enyekwa gị ihe ị ga-enyefe n'oche oche. Tinye akwụkwọ ọrụ ahụ na ndekọ ntozu ndị na-eweta ngwaahịa ma ọ bụ RFQ, na-ezo aka n'ụkpụrụ ndị ọ na-esetịpụ n'aha: I Q6A, I Q2(R2), USP <788>, USP <85>, USP <71>, yana ụkpụrụ ịdị n'ezi data MHRA ALCOA. Onye na-ebubata ihe nwere ike ịzaghachi akara nnabata nwere nọmba; ọ nweghị ike ịzaghachi “ịdị ọcha dị elu.”

Nweta Template nkọwapụta Nnwale kpuchiri akwụkwọ ọrụ ngalaba-site-ngalaba, usoro, akara nnabata, na ọdịda mode, dị njikere itinye aka na ntozu ndị na-ebubata ma ọ bụ RFQ.

Rịọ ụdị nkọwapụta

Nkpughe: MOL Mgbanwe nwere mmasị azụmahịa na ụkpụrụ mma peptide. Usoro dị n'elu bụ usoro na-anọpụ iche, enwere ike iji ya na ndị na-ebubata ihe ọ bụla tozuru oke.

irene@molchanges.com Avatar

Bingyan Gao

Ọkachamara na nyocha nyocha Ọkachamara isi: Nkewa na njirimara nke adịghị ọcha, Mmepe usoro HPLC/MS, chiral ịdị ọcha analysis, yana nrube isi na mba ụwa pharmacopoeias.

Profaịlụ: Bingyan Gao bụ "onye nche ọnụ ụzọ ámá" nke ịdị ọcha na ịdị mma peptide. Ọ maara nke ọma n'iji ngwa nyocha dị elu dị iche iche na ọkachamara n'ịzụlite ụzọ nkewa chromatographic ahaziri maka peptides gbanwetụrụ nke ukwuu.. O guzobela usoro profaịlụ adịghị ọcha siri ike nke na-abụghị naanị na-eme ka ngwaahịa dị ọcha nke 99% ma ọ bụ karịa mana ọ na-achọpụtakwa kpọmkwem ma kpochapụ adịghị ọcha nke nwere ike ịkpata immunogenicity. Site na nghota miri emi nke iwu FDA na EMA chọrọ maka ọgwụ peptide, ọ na-ahụ na ogbe ọ bụla ewepụtara na ụlọ ọrụ ahụ na-esonyere ya na Asambodo nyocha zuru oke na ikike. (COA).

Achọpụtara eziokwu & Ntuziaka ndezi
Nyochaa ya bụ: Ndị ọkachamara Okwu
Kesaa akụkọ a
Ụlọ Chọọ WhatsApp Ọrụ Ngwaahịa